Synthesis 2012; 44(15): 2396-2400
DOI: 10.1055/s-0031-1290408
paper
© Georg Thieme Verlag Stuttgart · New York

An Efficient Synthesis of 4-Chloro-2-pyrrolino[2,3-d]pyrimidin-6-one and Its 7-Substituted Analogues

Radhe K. Vaid*
Chemical Product Research and Development, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA, Fax: +1(317)2764507   Email: vaid_radhe_k@lilly.com
,
Jeremy T. Spitler
Chemical Product Research and Development, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA, Fax: +1(317)2764507   Email: vaid_radhe_k@lilly.com
,
Sathish Boini
Chemical Product Research and Development, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA, Fax: +1(317)2764507   Email: vaid_radhe_k@lilly.com
,
Scott A. May
Chemical Product Research and Development, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA, Fax: +1(317)2764507   Email: vaid_radhe_k@lilly.com
,
Richard C. Hoying
Chemical Product Research and Development, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA, Fax: +1(317)2764507   Email: vaid_radhe_k@lilly.com
› Author Affiliations
Further Information

Publication History

Received: 11 April 2012

Accepted after revision: 07 May 2012

Publication Date:
18 June 2012 (online)


Abstract

An efficient synthesis of 4-chloro-2-pyrrolino[2,3-d]pyrimidin-6-one was achieved in four steps starting from dimethyl malonate in 23% overall yield. This synthesis was demonstrated on 100 g scale to obtain 4-chloro-2-pyrrolino[2,3-d]pyrimidin-6-one in 98.5% purity. Similarly, 7-[(2,4-dimethoxyphenyl)methyl]-4-chloro[2,3-d]pyrimidin-6-one and 7-(α-methylbenzyl)-4-chloro[2,3-d]pyrimidin-6-one were synthesized by the reaction of methyl 2-(4,6-dichloropyrimidin-5-yl)acetate with an appropriately substituted benzylamine.

 
  • References

    • 1a Hill MD, Mohammad M. Chem.–Eur. J. 2008; 14: 6836
    • 1b Undheim K, Benneche T In Comprehensive Heterocyclic Chemistry II . Vol. 6. Katritzky AR, Rees CW, Scriven EF. V, McKillop A. Pergamon; Oxford: 1996: 93-231
    • 1c Lagoja IM. Chemistry & Biodiversity 2005; 2: 1
    • 1d Michael JP. Nat. Prod. Rep. 2005; 22: 627
  • 2 Petersen E, Schmidt DR. Expert Rev. Anti-Infect. Ther. 2003; 1: 175
  • 3 Nadal E, Olavarria E. Int. J. Clin. Pract. 2004; 58: 511
  • 4 Blum JL. Oncologist 2001; 6: 56
    • 5a Kçytepe S, Pasahan A, Ekinci E, SeÅkin T. Eur. Polym. J. 2005; 41: 121
    • 5b Gompper R, Mair H-J, Polborn K. Synthesis 1997; 696
    • 5c Kanbara T, Kushida T, Saito N, Kuwajima I, Kubota K, Yamamoto T. Chem. Lett. 1992; 583
  • 6 Shepherd TA, Dally RD, Joseph S. US Patent 120801 A1, 2010
  • 7 Sun L, Cui J, Liang C, Zhou Y, Nematalla A, Wang X, Chen H, Tang C, Wei J. Bioorg. Med. Chem. Lett. 2002; 12: 2153
    • 8a Davoll J. J. Chem. Soc. 1960; 131
    • 8b Diederichsen U, Schmitt HW. Eur. J. Org. Chem. 1998; 827
    • 8c Yarlagadda B, Chand S, Kotian P, Pravin L, Kumar VS. Patent WO2010/14930 A2, 2010
    • 8d Liang C, Sun L, Wei C, Tang PC, McMahon G, Hirth KP, Cui J. US Patent 183319 A1, 2002
    • 8e Hu W, Song C, Wang Q, Shen Z, Wang S, Chang J, Wang P, Pan Z, Guo X, Yu X. Bioorg. Med. Chem. Lett. 2010;  20:  7297
    • 8f Zhou J. PCT Int. Appl 2010083283, 2010
    • 9a Bell IM, Stump CA, Theberge CR, Gallicchio SN, Zartman CB, Selnick HG. Patent WO2007/61692 A2, 2007
    • 9b Bellian M, Stump CA. Patent WO2006/29153 A2, 2006
    • 9c Neelamkavil S, Francis Boyle CD, Harris JM, Stamford AW, Hao J, Neustadt BR, Chackalamannil S, Xia Y, Greenlee WJ. Patent WO2010/9207 A1, 2010
    • 10a Janza B, Studer A. Org. Lett. 2006; 8: 1875
    • 10b House HO, Sauter FJ, Kenyon WG, Riehl JJ. J. Org. Chem. 1968;  33: 957
  • 11 Chern C, Huang Y, Kan WM. Tetrahedron Lett. 2003; 44: 1039 ; and references cited therein
  • 12 The structures of compounds 18 and 20 shown in Figure 2 are postulated based upon the mass data